Clinical Trials Logo

Recurrence clinical trials

View clinical trials related to Recurrence.

Filter by:

NCT ID: NCT04368507 Completed - Clinical trials for Colorectal Cancer Metastatic

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients

Start date: August 9, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

To evaluate the safety, tolerability, pharmacokinetics and antitumor activity of YYB101 with Irinotecan, patients who are metastatic or recurrent Colorectal Cancer Patients.

NCT ID: NCT04357080 Completed - Urethral Stricture Clinical Trials

Factors Predicting Urethral Stricture Recurrence After Dorsal Onlay Augmented, Buccal Mucosal Graft Urethroplasty

Start date: July 15, 2020
Phase:
Study type: Observational

In this observational study, the investigators will evaluate potential risk factors associated with urethral stricture recurrence after augmentation anterior urethroplasty using dorsal onlay buccal mucosal Graft during the past 10 years. Patients' medical files will be reviewed for data relevant to demographics, clinical and operative characteristics. data will be analyzed using the appropriate statistical tests and the independent predictors of urethroplasty outcome will be identified.

NCT ID: NCT04326088 Completed - Clinical trials for Head and Neck Cancer

Postoperative Complication After Free Flap Reconstruction for Head and Neck Cancer

Start date: April 1, 2018
Phase:
Study type: Observational

This study was designed to investigate the outcome of free-flap reconstruction surgery following head and neck cancer resection between primary and recurrent head and neck cancer patients.

NCT ID: NCT04319861 Completed - Recurrence Clinical Trials

Anal Fistula Plug, a Retrospective Study

Start date: August 1, 2008
Phase: N/A
Study type: Interventional

In this study, we retrospectively reviewed clinical data of patients who were treated with an anal fistula plug for trans-sphincteric anal fistulas, and evaluated the long-term therapeutic effect of an anal fistula plug and the risk factors impacting anal fistula healing. In addition, we assessed the effects of post-operative changes on anal function, as well as the risk factors affecting anal function.

NCT ID: NCT04319263 Completed - Bladder Cancer Clinical Trials

Oncological Outcomes of Different Patterns of Tumor Recurrence at First Evaluation After Bacillus Calmette-Guérin Induction Therapy for Intermediate and High Risk Non Muscle Invasive Bladder Cancer

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

This retrospective study aimed at assessment of different patterns (morphological and pathological) of tumor recurrence found at first evaluation after BCG induction therapy (3 months cystoscopy) for intermediate and high-risk NMIBC and its prognostic implications at a tertiary referral center.

NCT ID: NCT04317963 Completed - Clinical trials for Clostridium Difficile Infection

Real-world Evaluation of Bezlotoxumab for the Management of Clostridioides Difficile Infection

Start date: February 12, 2020
Phase:
Study type: Observational

This is a retrospective case:control study examining the use of adjunctive bezlotoxumab to standard C. difficile infection (CDI) treatment compared to standard CDI treatment alone in patients with CDI seen in an academic medical center's specialty outpatient clinic.

NCT ID: NCT04307056 Completed - Prostate Cancer Clinical Trials

Evaluation of HIFU in TREATMENT OF LOCALIZED PROSTATE CANCER and OF RECURRENCE AFTER RADIOTHERAPY

HIFI
Start date: March 23, 2015
Phase: N/A
Study type: Interventional

to compare the efficacy of HIFU treatment with standard treatment in two situations: 1. as first-line cancer treatment, HIFU is compared to radical prostatectomy. 2. for patients with recurrence after external beam radiotherapy, HIFU treatment is compared to radical prostatectomy.

NCT ID: NCT04271371 Completed - Smoking Clinical Trials

Preventing Relapse to Smoking Among Prisoners After Release

PROSPER
Start date: August 8, 2019
Phase:
Study type: Observational

Prisoners experience huge health inequalities, and their exceptionally high smoking prevalence (five times the national average) contributes significantly to their high mortality. Since the introduction of smoke-free polices across Her Majesty's Prison and Probation Service (HMPPS) in England and Wales, prisoners are now obliged to abstain from smoking while held in prison. This represents a unique opportunity to promote lifelong cessation in this highly disadvantaged and marginalised group. However, evidence suggests most prisoners intend to resume smoking as soon as possible after release. A systematic review of prison smoke-free polices worldwide concluded that there was a need for new research to identify effective strategies to reduce relapse in these individuals.

NCT ID: NCT04269811 Completed - Clinical trials for Relapse Rate After Allo-HSCT

Flu-Bu-Mel Conditioning Regimen for Myeloid Disease

Start date: January 15, 2020
Phase: Phase 2
Study type: Interventional

For patients with acute myeloid leukemia (AML) or myelodyspasia syndrome undergoing allo-HSCT, the conditioning regimen will be 5-day Fludarabine, 2-day Busulifan and 2-day melphalan

NCT ID: NCT04264962 Completed - Clinical trials for Hepatocellular Carcinoma

Yang Yin Fu Zheng Jie Du Therapy in Recurrence of Hepatocellular Carcinoma Less Than 3 cm in Diameter

YYFZJDTRHCLT3D
Start date: January 1, 2017
Phase: Early Phase 1
Study type: Interventional

Clinical research of Yang Yin Fu Zheng Jie Du therapy in recurrence of Hepatocellular Carcinoma less than 3 cm in diameter.The purpose of this study is to observe the efficacy of routine medical care combined with Yang Yin Fu Zheng Jie Du therapy in 1 year recurrence for patients belong to Hepatocellular Carcinoma less than 3 cm in diameter.